- Transition to Research Independence: Funding and Grantsmanship February 13, 2024
- Frontiers in Cancer Immunotherapy 2024 May 21 - May 23, 2024
- Cancer Metabolism and Signaling in the Tumor Microenvironment April 17, 2024
Events by TopicTransition to Research Independence: Funding and GrantsmanshipFebruary 13, 2024More
Join The Academy as Dr. Jaime Rubin, Vice Chair for Investigator Development at Columbia University, addresses relevant topics and skills required for successful funding and grantsmanship.Frontiers in Cancer Immunotherapy 2024May 21 - May 23, 2024More
This symposium presents a remarkable opportunity to convene with other researchers, clinicians, and industry leaders to discuss the extraordinary progress and immense potential of new drug therapies and technologies in paving the way for a brighter future in cancer treatment.Cancer Metabolism and Signaling in the Tumor MicroenvironmentApril 17, 2024More
Scientists working in basic, translational, and clinical cancer metabolism research are invited to join the Academy in New York on April 17th to discuss the intersection between cell signaling and metabolism.
Career Exploration Resources
Resources for EducatorsTransition to Research Independence: Funding and GrantsmanshipFebruary 13, 2024More
Join The Academy as Dr. Jaime Rubin, Vice Chair for Investigator Development at Columbia University, addresses relevant topics and skills required for successful funding and grantsmanship.
The Leon Levy Scholarships in Neuroscience (LLSN) aim to promote groundbreaking neuroscience research in the five boroughs of New York City. The scholarships support the most innovative young researchers at a critical stage of their careers—their postdoctoral research—as they develop the new ideas and directions that will help establish them as independent neuroscientists.
News & Publications by Topic
For the Press
Contact UsOur Mission: Science for the Public GoodMore
As the New York Academy of Sciences continues into its third century, Nicholas Dirks is at the helm of an extraordinary organization with a talented staff, a global community of more than 20,000 Members, and a network of top-echelon leaders in science, industry, academia, government and public policy. Bringing all these people together, the Academy is taking on COVID-19 and other world-wide challenges with the best solutions that science, technology, and bright minds can offer.